Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02143050
Title Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors James Graham Brown Cancer Center
Indications

melanoma

Therapies

Dabrafenib + Metformin + Trametinib

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST